| Online-Ressource |
Verfasst von: | Mainz, Jochen G. [VerfasserIn]  |
| Schumacher, Ulrike [VerfasserIn]  |
| Schädlich, Katja [VerfasserIn]  |
| Hentschel, Julia [VerfasserIn]  |
| Koitschev, Christiane [VerfasserIn]  |
| Koitschev, Assen [VerfasserIn]  |
| Riethmüller, Joachim [VerfasserIn]  |
| Prenzel, Freerk [VerfasserIn]  |
| Sommerburg, Olaf [VerfasserIn]  |
| Wiedemann, Bärbel [VerfasserIn]  |
| Staab, Doris [VerfasserIn]  |
| Gleiber, Wolfgang [VerfasserIn]  |
| Fischer, Rainald [VerfasserIn]  |
| Beck, James F. [VerfasserIn]  |
| Arnold, Christin [VerfasserIn]  |
| Schien, Claudia [VerfasserIn]  |
| Nader, Anika [VerfasserIn]  |
| Henn, Constance [VerfasserIn]  |
| Smaczny, Christina [VerfasserIn]  |
| Werner, Claudius [VerfasserIn]  |
| Hebestreit, Helge [VerfasserIn]  |
| Heuer, Hans Erberhard [VerfasserIn]  |
| Schmidt, Sebastian [VerfasserIn]  |
| Eichhorn, Corinna [VerfasserIn]  |
| Schiller, Isabella [VerfasserIn]  |
| Roessler, Andrea [VerfasserIn]  |
| Baumann, Ingo [VerfasserIn]  |
Titel: | Sino nasal inhalation of isotonic versus hypertonic saline (6.0 %) in CF patients with chronic rhinosinusitis |
Titelzusatz: | results of a multicenter, prospective, randomized, double-blind, controlled trial |
Verf.angabe: | Jochen G. Mainz, Ulrike Schumacher, Katja Schädlich, Julia Hentschel, Christiane Koitschev, Assen Koitschev, Joachim Riethmüller, Freerk Prenzel, Olaf Sommerburg, Bärbel Wiedemann, Doris Staab, Wolfgang Gleiber, Rainald Fischer, James F. Beck, Christin Arnold, Cooperators, Claudia Schien, Anika Nader, Constance Henn, Christina Smaczny, Claudius Werner, Helge Hebestreit, Hans Eberhard Heuer, Sebastian Schmidt, Corinna Eichhorn, Isabella Schiller, Andrea Roessler, Ingo Baumann |
E-Jahr: | 2016 |
Jahr: | 5 June 2016 |
Umfang: | 10 S. |
Fussnoten: | Gesehen am 25.05.2020 |
Titel Quelle: | Enthalten in: Journal of cystic fibrosis |
Ort Quelle: | Amsterdam [u.a.] : Elsevier Science, 2002 |
Jahr Quelle: | 2016 |
Band/Heft Quelle: | 15(2016), 6, Seite e57-e66 |
ISSN Quelle: | 1873-5010 |
Abstract: | BACKGROUND: Chronic rhinosinusitis is a hallmark of Cystic fibrosis (CF) impairing the patients' quality of life and overall health. However, therapeutic options have not been sufficiently evaluated. Bronchial inhalation of mucolytic substances is a gold standard in CF therapy. Previously, we found that sinonasal inhalation of dornase alfa as vibrating aerosol reduces symptoms of chronic rhinosinusitis more effectively than NaCl 0.9% (net treatment benefit: -5.87±2.3 points, p=0.017; SNOT-20 total score). This multicenter study compares the effect of NaCl 6.0% vs. NaCl 0.9% following the protocol from our preceding study with dornase alfa. - METHODS: Sixty nine CF patients with chronic rhinosinusitis in eleven German CF centers were randomized to receive sinonasal vibrating inhalation of either NaCl 6.0% or NaCl 0.9% for 28days. After 28days of wash-out, patients crossed over to the alternative treatment. The primary outcome parameter was symptom score in the disease-specific quality of life Sino-Nasal Outcome Test-20 (SNOT-20). Additionally, pulmonary function was assessed, as well as rhinomanometry and inflammatory markers in nasal lavage (neutrophil elastase, interleukin (IL)-1β, IL-6, and IL-8) in a subgroup. - RESULTS: Both therapeutic arms were well tolerated and showed slight improvements in SNOT-20 total scores (NaCl 6.0%: -3.1±6.5 points, NaCl 0.9%: -5.1±8.3 points, ns). In both treatment groups, changes of inflammatory parameters in nasal lavage from day 1 to day 29 were not significant. We suppose that the irritating properties of NaCl 6.0% reduced the suitability of the SNOT-20 scores as an outcome parameter. Alternative primary outcome parameters such as MR-imaging or the quantity of sinonasal secretions mobilized with both saline concentrations were, however, not feasible. - CONCLUSION: Sinonasal inhalation with NaCl 6.0% did not lead to superior results vs. NaCl 0.9%, whereas dornase alfa had been significantly more effective than NaCl 0.9%. |
DOI: | doi:10.1016/j.jcf.2016.05.003 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.1016/j.jcf.2016.05.003 |
| DOI: https://doi.org/10.1016/j.jcf.2016.05.003 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | Administration, Inhalation |
| Adolescent |
| Adult |
| Child |
| Chronic Disease |
| Cystic Fibrosis |
| Drug Monitoring |
| Female |
| Humans |
| Hypertonic saline |
| Inflammation |
| Male |
| Nasal lavage |
| Nasal Lavage |
| Quality of Life |
| Respiratory Function Tests |
| Rhinitis |
| Rhinomanometry |
| Saline Solution, Hypertonic |
| Sino-Nasal Outcome Test-20 |
| Sinusitis |
| Sodium chloride |
| Treatment Outcome |
K10plus-PPN: | 1698758308 |
Verknüpfungen: | → Zeitschrift |
Sino nasal inhalation of isotonic versus hypertonic saline (6.0 %) in CF patients with chronic rhinosinusitis / Mainz, Jochen G. [VerfasserIn]; 5 June 2016 (Online-Ressource)